Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 5/14/2017
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / 2||UN / IM|
Administered by: Other Purchased by: Other
Symptoms: Dizziness, Presyncope, Exercise tolerance decreased, Orthostatic intolerance, Tilt table test positive
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? No
Other Medications: No other medications
Current Illness: HPV immunisation
Diagnostic Lab Data: A tilt table test at the department (unknown date): showed orthostatic intolerance, but the patient does not fulfill the diagnostic criteria for POTS
CDC 'Split Type': WAES1512DNK010892
Write-up:Information has been received from Sanofi Pasteur MSD (manufacturer control number # 2015001188) as part of business agreement on 21-DEC-2015. Case received from a physician on 17-DEC-2015. A 13-year-old female adolescent patient received GARDASIL, (batch number unknown) via intramuscular route on 14-Apr-2010. Other suspect products included: Gardasil, (batch number unknown, Dose 2) administered via intramuscular route on 16-Jun-2010 -GARDASIL, (batch number unknown , Dose 3) administered via intramuscular route on 13-Dec-2010. The patient experienced Near syncope in DEC-2010, Dizziness in DEC-2010 and Exercise capacity decreased on an unknown date. Additional investigations included Tilt Table Test orthostatic intolerance n/a on an unknown date.Other HA comment: A tilt table test at the department showed orthostatic intolerance, but the patient does not fulfill the diagnostic criteria for POTS. Other medicines/and vaccines: unknown. 6 months after dose 2 of GARDASIL the patient attends a basketball tournament and get near syncope, then experience it several times with dizziness. Physical activity significantly reduced now.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166